A number of listeriosis cases in adults who are immunocompromised secondary to infliximab use have been reported.1,11 Infliximab is a tumor necrosis factor-α (TNF-α) inhibitor commonly used in treatment of rheumatoid arthritis and Crohn’s disease. The gene discussed is TNF; the disease is listeriosis.